Clinical Report: Kazachstania slooffiae Fungemia in an Immunocompromised Patient

Overview

This report describes the first documented case of Kazachstania slooffiae fungemia in a 77-year-old immunocompromised male with gastrointestinal abnormalities. Diagnosis was achieved using MALDI-TOF mass spectrometry and DNA sequencing, and treatment with micafungin led to favorable outcomes. A literature review highlights K. slooffiae as a rare opportunistic pathogen primarily affecting critically ill patients with GI tract abnormalities.

Background

Kazachstania slooffiae is a yeast species commonly found in animal gastrointestinal tracts and environmental sources but rarely reported as a human pathogen. Previously, only two nonbloodstream human infections have been documented. The genus Kazachstania includes species involved in fermentation and is considered commensal in animals such as swine. Increasing incidence of uncommon invasive fungal infections underscores the need to understand emerging pathogens like K. slooffiae, especially in immunocompromised hosts with anatomical GI abnormalities.

Data Highlights

Key Findings

• Kazachstania slooffiae can cause bloodstream infections in humans, particularly in immunocompromised patients with GI tract abnormalities.
• Diagnosis requires advanced techniques such as MALDI-TOF mass spectrometry and DNA sequencing due to limitations of conventional methods.
• Prior to this case, only two nonbloodstream K. slooffiae infections had been reported.
• Antifungal therapy with echinocandins like micafungin has been effective in treating K. slooffiae fungemia.
• Patients with complex medical histories including prior surgeries, malnutrition, and immunosuppression are at increased risk.

Clinical Implications

Clinicians should consider Kazachstania slooffiae as a potential cause of fungemia in immunocompromised patients with gastrointestinal abnormalities. Prompt use of advanced diagnostic tools is critical for accurate identification. Early initiation of echinocandin antifungal therapy may improve outcomes in these rare but serious infections.

Conclusion

Kazachstania slooffiae is an emerging opportunistic fungal pathogen capable of causing bloodstream infections in vulnerable patients. Awareness and timely management are essential to optimize clinical outcomes.

References

1. Case Study and Literature Review (2025) -- Fungemia Caused by Kazachstania slooffiae